← Back to Search

Behavioural Intervention

Digital, evidence-based behavioral health program for smoking cessation for Smoking Cessation

N/A
Waitlist Available
Led By Christi Patten, PhD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 and 12 weeks
Awards & highlights

Study Summary

This trial will help assess how well access to technology and coaching affects people's ability to quit smoking in rural areas.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Trial engagement
Secondary outcome measures
Smoking abstinence
Use of evidence-based smoking cessation treatment

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Loaner Digital Device + Coaching SupportExperimental Treatment2 Interventions
Subjects will receive a 12-week, digital, evidence-based behavioral health program for smoking cessation delivered through the patient portal and a written guide on existing digital access resources along with any other necessary material. Participants in this group will also receive a loaned Bluetooth enabled iPad with data plan coverage for the study duration plus up to six coaching call, 15-20 minutes in duration.
Group II: Loaner Digital DeviceExperimental Treatment2 Interventions
Subjects will receive a 12-week, digital, evidence-based behavioral health program for smoking cessation delivered through the patient portal and a written guide on existing digital access resources along with any other necessary material. Participants in this group will also receive a loaned Bluetooth enabled iPad with data plan coverage for the study duration.
Group III: Control Condition - No additional study interventionActive Control1 Intervention
Subjects will receive a 12-week, digital, evidence-based behavioral health program for smoking cessation delivered through the patient portal and a written guide on existing digital access resources along with any other necessary material.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Digital, evidence-based behavioral health program for smoking cessation
2022
N/A
~90
Coaching Support
2022
N/A
~430

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,207 Previous Clinical Trials
3,767,050 Total Patients Enrolled
Christi Patten, PhDPrincipal InvestigatorMayo Clinic
3 Previous Clinical Trials
128 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~28 spots leftby Apr 2025